Baidu
map

A Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of Proposed Biosimilar GB242 and Reference Infliximab in Healthy Subjects

Zhang, T; Chen, GH; Liu, C; Zu, L; Wang, Q; Wang, YT; Lv, J; An, YZ; Dong, LH; Cheng, HY; Ren, SB; Wang, Q; Zheng, QS; Song, HF; Fang, Y

Fang, Y (reprint author), Peking Univ, Peoples Hosp, Dept Pharm, Beijing, Peoples R China.

BIODRUGS, 2019; 33 (1): 93

Abstract

The objective of this study was to compare the pharmacokinetics (PKs), safety, and immunogenicity of GB242 as a potential biosimilar infliximab with t......

Full Text Link


Baidu
map
Baidu
map
Baidu
map